Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2019 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Macrophage CD5L is a target for cancer immunotherapy.
EBioMedicine. 2023 May;91:104555. doi: 10.1016/j.ebiom.2023.104555. Epub 2023 Apr 11.
EBioMedicine. 2023.
PMID: 37054630
Free PMC article.
CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3.
Sanjurjo L, Aran G, Téllez É, Amézaga N, Armengol C, López D, Prats C, Sarrias MR.
Sanjurjo L, et al. Among authors: tellez e.
Front Immunol. 2018 Mar 12;9:480. doi: 10.3389/fimmu.2018.00480. eCollection 2018.
Front Immunol. 2018.
PMID: 29593730
Free PMC article.
Item in Clipboard
Multifaceted Roles of CD5L in Infectious and Sterile Inflammation.
Sanchez-Moral L, Ràfols N, Martori C, Paul T, Téllez É, Sarrias MR.
Sanchez-Moral L, et al. Among authors: tellez e.
Int J Mol Sci. 2021 Apr 15;22(8):4076. doi: 10.3390/ijms22084076.
Int J Mol Sci. 2021.
PMID: 33920819
Free PMC article.
Review.
Item in Clipboard
Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14.
Sanjurjo L, Castelblanco E, Julve J, Villalmanzo N, Téllez É, Ramirez-Morros A, Alonso N, Mauricio D, Sarrias MR.
Sanjurjo L, et al. Among authors: tellez e.
Antioxidants (Basel). 2023 May 11;12(5):1083. doi: 10.3390/antiox12051083.
Antioxidants (Basel). 2023.
PMID: 37237950
Free PMC article.
Item in Clipboard
Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators.
Sánchez-Rodríguez MB, Téllez É, Casulleras M, Borràs FE, Arroyo V, Clària J, Sarrias MR.
Sánchez-Rodríguez MB, et al. Among authors: tellez e.
Front Immunol. 2022 Mar 7;13:842996. doi: 10.3389/fimmu.2022.842996. eCollection 2022.
Front Immunol. 2022.
PMID: 35330909
Free PMC article.
Item in Clipboard
CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content.
Bárcena C, Aran G, Perea L, Sanjurjo L, Téllez É, Oncins A, Masnou H, Serra I, García-Gallo M, Kremer L, Sala M, Armengol C, Sancho-Bru P, Sarrias MR.
Bárcena C, et al. Among authors: tellez e.
EBioMedicine. 2019 May;43:513-524. doi: 10.1016/j.ebiom.2019.04.052. Epub 2019 May 8.
EBioMedicine. 2019.
PMID: 31076347
Free PMC article.
Item in Clipboard
CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78).
Aran G, Sanjurjo L, Bárcena C, Simon-Coma M, Téllez É, Vázquez-Vitali M, Garrido M, Guerra L, Díaz E, Ojanguren I, Elortza F, Planas R, Sala M, Armengol C, Sarrias MR.
Aran G, et al. Among authors: tellez e.
FASEB J. 2018 Jul;32(7):3878-3891. doi: 10.1096/fj.201700941RR. Epub 2018 Feb 20.
FASEB J. 2018.
PMID: 29465313
Item in Clipboard
Cite
Cite